Cocrystal pharma to present at august 20th virtual investor summit microcap event

New york, ny / accesswire / august 15, 2024 / cocrystal pharma (nasdaq:cocp), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses and noroviruses, announces that management will present a company overview at the virtual investor summit microcap forum being held tuesday, august 20, 2024. management will be available for 1-on-1 meetings throughout the day.
COCP Ratings Summary
COCP Quant Ranking